Other Intangible Assets, Net (Details) - USD ($) $ in Millions	3 Months Ended	9 Months Ended
	Jun. 30, 2015	Sep. 30, 2015		Sep. 30, 2014	Dec. 31, 2014	Dec. 31, 2013
Intangible Assets (Excluding Goodwill) [Line Items]
Amortized intangible assets		$ 9,763.5			$ 4,846.9
Other intangible assets, gross		11,245.9			6,396.9
Less: Accumulated amortization		(1,795.3)	[1]		(1,462.5)
Other intangible assets, net		9,450.6		$ 5,227.4	4,934.4	$ 2,312.6
Other Disclosures
Acquisitions		5,473.7		3,332.8
Impairment charges		523.3		188.0
Change in fair value of contingent consideration		196.5		(26.3)
Estimates of Annual Amortization
2015		470.0
2016		470.0
2017		470.0
2018		470.0
2019		470.0
Lumena and Lotus Tissue Repair
Other Disclosures
Change in fair value of contingent consideration		(203.4)
Currently Marketed Products
Intangible Assets (Excluding Goodwill) [Line Items]
Amortized intangible assets		9,388.5			4,816.9
Less: Accumulated amortization		(1,734.9)
Other intangible assets
Intangible Assets (Excluding Goodwill) [Line Items]
Amortized intangible assets		375.0	[2]		30.0
Less: Accumulated amortization		(60.4)
IPR&D
Intangible Assets (Excluding Goodwill) [Line Items]
Unamortized intangible assets		1,482.4			$ 1,550.0
IPR&D | Meritage and Foresight
Other Disclosures
Acquisitions		475.0
SHP602 IPR&D
Other Disclosures
Impairment charges				166.0
SHP613
Other Disclosures
Impairment charges				$ 22.0
Currently marketed products and royalty rights | NPS Pharma
Other Disclosures
Acquisitions		4,993.0
SHP625
Other Disclosures
Unamortized intangible assets, fair value		$ 120.4
Impairment charges	$ 346.6
SHP608
Other Disclosures
Impairment charges	$ 176.7

[1] Comprising $1,734.9 million of accumulated amortization for intellectual property rights acquired for currently marketed products and $60.4 million for other intangible assets

[2] Other intangible assets primarily comprises of royalty right assets acquired with NPS Pharma. Comprising $1,734.9 million of accumulated amortization for intellectual property rights acquired for currently marketed products and $60.4 million for other intangible assets.